COVID-19

Pharma Courses 
PAGE Admission

  • U.S. Food and Drug Administration provided an update on its efforts to ensure the availability of alcohol-based sanitizer to help meet the demand for hand sanitizer during the COVID-19 pandemic. As a result of the agency’s significant flexibility, more than 1,500 additional manufacturers have registered with the agency to produce hand sanitizer. At the same time, the agency is addressing safety concerns related to products being sold that are not in line with the FDA’s policy and others being marketed with unproven claims.

  • Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. The aim is to mitigate the disruption of clinical research in Europe and therefore the negative effects of the pandemic, without compromising on quality and safety. These recommendations are an important part of the overall strategy in finding treatments and a vaccine to protect citizens against the coronavirus.

  • Using machine learning, a team of computer scientists and biologists from Western University identified an underlying genomic signature for 29 different COVID-19 virus DNA sequences.

  • 28 April 2020
    Pharmacist Hero Vol 5

    PharmaTutor facilitating these Pharmacy warriors who are contributing against fight of COVID-19. This is Volume 5. We shall keep posting list of more Pharmacist Heroes.

    Any pharmacist from industry, academics, researcher or community pharmacist who contributing actively for fight aganist COVID-19 can send their details.

  • 28 April 2020
    Vacancy for Project Associate at Indian Institute of Toxicology Research

    CSIR-Indian Institute of Toxicology Research, Lucknow, a constituent laboratory of Council of Scientific & Industrial Research, was established in 1965. This multidisciplinary research institute with the motto Safety to Environment and Health and Service to Industry addresses problems critical to human health and environment.

    The eligible and interested candidates may attend the interview for purely temporary engagement as “Senior Project Associate” and“Project Associate-II” for COVID-19 testing project. The eligibility criterion is as follows.

  • Amid the rapidly evolving global coronavirus disease 2019 (COVID-19) pandemic that has already had profound effects on public health and medical infrastructure across the globe, many questions remain about its impact on child health. New research published in the Journal of Clinical Virology indicates that the vulnerability of neonates and children and their role in the spread of the virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) should be included in preparedness and response plans.

  • Government-enforced social isolation may help relatively affluent populations limit the spread of COVID-19, but these measures can be devasting for the nearly 1 billion people around the globe currently dwelling in urban slums, where physical space is scarce, and many rely on daily wage labor for survival.

  • People with certain heart diseases may be more susceptible to worse outcomes with COVID-19, but the reason why has remained unknown. New research from Mayo Clinic indicates that in patients with one specific type of heart disease obstructive hypertrophic cardiomyopathy (HCM) the heart increases production of the ACE2 RNA transcript and the translated ACE2 protein.

Subscribe to COVID-19